FDA Approves Nexium for Use in Children Ages 1-11 Years
"Children prescribed this drug should be monitored by their physicians for any adverse drug reactions."
The U.S. Food and Drug Administration approved Nexium for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease . via Food and Drug Administration